Analysts Are Revising Their Forecasts NYSE:BBY, NYSE:SWN, NASDAQ:INZY, NYSE:NWN

BEST BUY (NYSE:BBY) EARNINGS INFORMATION (NYSE:BBY)

Best Buy last announced its quarterly earnings results on February 25th, 2021. The technology retailer reported $3.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.47 by $0.01. Best Buy has generated $6.07 earnings per share over the last year and currently has a price-to-earnings ratio of 15.6. Best Buy has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, May 19th, 2021 based off prior year’s report dates.

IS BEST BUY A BUY RIGHT NOW? (NYSE:BBY)

23 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Best Buy in the last twelve months. There are currently 1 sell rating, 8 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Best Buy stock.
Best Buy

SOUTHWESTERN ENERGY EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NYSE:SWN)

IS SOUTHWESTERN ENERGY A BUY RIGHT NOW? (NYSE:SWN)

16 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Southwestern Energy in the last year. There are currently 2 sell ratings, 11 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Southwestern Energy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWN, but not buy additional shares or sell existing shares.
Southwestern Energy

INOZYME PHARMA EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:INZY)

IS INOZYME PHARMA A BUY RIGHT NOW? (NASDAQ:INZY)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Inozyme Pharma in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Inozyme Pharma stock.
Inozyme Pharma

NORTHWEST NATURAL EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NYSE:NWN)

IS NORTHWEST NATURAL A BUY RIGHT NOW? (NYSE:NWN)

5 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Northwest Natural in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Northwest Natural stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NWN, but not buy additional shares or sell existing shares.
Northwest Natural